Daniel Rootman is an Ophthalmology physician affiliated with University of California, Los Angeles. OpenAlex indexes 254 publications with 2,298 citations (h-index 26); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Stein Plz
Los Angeles, CA 900957006
Telephone
626-817-4747Registry record last updated 21 Mar 2017.
Clinical trials
- Hyaluronic Acid Gels for Lower Lid Retraction
Sponsor: University of California, Los Angeles
- Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Sponsor: University of California, Los Angeles
- Study Trial of Dexamethasone Use for Alleviation of Symptoms After Scleral Buckle Eye Surgery
Sponsor: University of Toronto
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202538 payments$36,229openpaymentsdata.cms.gov ↗
- ARGENX US, INC.Program year202521 payments$23,483openpaymentsdata.cms.gov ↗
- BIOTISSUE HOLDINGS INC.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Estimating apparent age using artificial intelligence: Quantifying the effect of blepharoplasty
Journal of Plastic Reconstructive & Aesthetic Surgery
2023 - Ensemble neural network model for detecting thyroid eye disease using external photographs
British Journal of Ophthalmology
2022 - Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab
Ophthalmic Plastic and Reconstructive Surgery
2022 - Google Searches for Thyroid Eye Disease After Regulatory Approval of Teprotumumab
JAMA Ophthalmology
2022 - Early Experience With the Clinical Use of Teprotumumab in a Heterogenous Thyroid Eye Disease Population
Ophthalmic Plastic and Reconstructive Surgery
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”